Clinical Trials Browser

Phase 2 × milademetan × Clear all

Testicular Germ Cell Tumor, Adenocarcinoma of Lung, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Adrenocortical Carcinoma, Cholangiocarcinoma

NCT05932667 2023-12-21

DEMETER

Phase 2 Terminated

1 enrolled

Breast

Breast Neoplasms

Clinical Trials

Milademetan in Advanced/Metastatic Solid Tumors

DEMETER